Connection

Antonio Gasbarrini to Colitis, Ulcerative

This is a "connection" page, showing publications Antonio Gasbarrini has written about Colitis, Ulcerative.
Connection Strength

0.739
  1. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005 Apr; 100(4):886-95.
    View in: PubMed
    Score: 0.145
  2. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct; 8(5):231-3.
    View in: PubMed
    Score: 0.140
  3. Anti-tumor necrosis factor a therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol. 2019 Mar 28; 25(12):1465-1477.
    View in: PubMed
    Score: 0.096
  4. Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel. Inflamm Bowel Dis. 2018 09 15; 24(10):2198-2210.
    View in: PubMed
    Score: 0.092
  5. Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study. Dig Liver Dis. 2019 02; 51(2):218-225.
    View in: PubMed
    Score: 0.092
  6. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Drugs Today (Barc). 2018 Feb; 54(2):123-136.
    View in: PubMed
    Score: 0.088
  7. ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa. Anal Bioanal Chem. 2017 Oct; 409(26):6097-6111.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.